The importance of Minerva Surgical v Hologic

On January 8, 2021, the US Supreme Court agreed to hear Minerva Surgical v Hologic to consider whether an inventor or those in privity with the inventor may assert patent invalidity as a defence against a patent infringement suit for the inventor’s patent.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Medtech

Fed Circuit rejects Minerva patent invalidation bid

12 August 2022 Hologic patent invented by Minerva’s founder cannot be invalidated | Patent in dispute concerns device used to treat uterine bleeding | US Court of Appeals.

Big Pharma

Minerva: less risk for inventors, more work for the courts

1 July 2021 The US Supreme Court opinion in Minverva v Hologic means that inventors will now have a far narrower scope to be able to challenge the validity of their own patents in defence proceedings—a decision that was controversial among the judges.

Americas

Breaking: SCOTUS says inventors can challenge their patents, but imposes limits

29 June 2021 The US Supreme Court has upheld the doctrine of assignor estoppel in a dispute between Minerva and Hologic but has narrowed its scope.

More on this story

Medtech

Fed Circuit rejects Minerva patent invalidation bid

12 August 2022 Hologic patent invented by Minerva’s founder cannot be invalidated | Patent in dispute concerns device used to treat uterine bleeding | US Court of Appeals.

Big Pharma

Minerva: less risk for inventors, more work for the courts

Americas

Breaking: SCOTUS says inventors can challenge their patents, but imposes limits

29 June 2021 The US Supreme Court has upheld the doctrine of assignor estoppel in a dispute between Minerva and Hologic but has narrowed its scope.

More on this story

Medtech

Fed Circuit rejects Minerva patent invalidation bid

12 August 2022 Hologic patent invented by Minerva’s founder cannot be invalidated | Patent in dispute concerns device used to treat uterine bleeding | US Court of Appeals.

Big Pharma

Minerva: less risk for inventors, more work for the courts

Americas

Breaking: SCOTUS says inventors can challenge their patents, but imposes limits

29 June 2021 The US Supreme Court has upheld the doctrine of assignor estoppel in a dispute between Minerva and Hologic but has narrowed its scope.